ELUT (Elutia) Quality Rank


ELUT Elutia Inc ELUT
36 GF Score
Price $0.94
GF Value $0.91
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Elutia Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Elutia Quality Rank Related Terms

ELUT
36GF Score
Elutia Inc ELUT
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Elutia (ELUT) Overvalued in 2026?

Based on GuruFocus' analysis, Elutia stock appears to be overvalued. The current stock price of $0.94 is trading 2.8% above its estimated GF Value™ of $0.91. GuruFocus considers Elutia to be Fairly Valued.

Key valuation signals for ELUT:

  • Quality Rank:
  • GF Value™: $0.91 vs. price of $0.94 (2.8% above fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the ELUT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elutia Business Description

Address 20 Firstfield Road, Gaithersburg, MD, USA, 20878
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
36GF Score

Get the complete analysis for ELUT

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.94
Price
$0.91
GF Value